NCT01876251 2019-03-15A Study Evaluating The PF-03084014 In Combination With Docetaxel In Patients With Advanced Breast CancerPfizerPhase 1 Terminated30 enrolled 29 charts
NCT02299635 2019-01-08A Study Evaluating PF-03084014 In Patients With Advanced Breast Cancer With Or Without Notch AlterationsPfizerPhase 2 Terminated19 enrolled 9 charts